Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1Phase 2 Interventional

A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19

ClinicalTrials.gov ID: NCT05162365

Public ClinicalTrials.gov record NCT05162365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a dose-finding, inferentially seamless Phase 1/2 study evaluating the safety, tolerability and efficacy of IBI314 in Ambulatory Patients with COVID-19.

Study identification

NCT ID
NCT05162365
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
248 participants

Conditions and interventions

Conditions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2022 (Actual)
Primary completion
Jun 29, 2022 (Actual)
Completion
Nov 18, 2022 (Actual)
Last update posted
Dec 18, 2023

2022

United States locations

U.S. sites
19
U.S. states
5
U.S. cities
15
Facility City State ZIP Site status
Sobh Anaheim California 92806 —
Long Beach Clinical Trials, LLC Long Beach California 90806 —
Acclaim Clinical Research San Diego California 92120 —
Herco Research Center, Inc. Coral Gables Florida 33134 —
Midland Florida Clinical Research Center - Inf. Disease/Infectiology DeLand Florida 32720 —
Palm Springs Research Institute Hialeah Florida 33012 —
Sweet Hope Research Specialty, Inc Hialeah Florida 33016 —
Prestige Clinical Research Center Inc Miami Florida 33133 —
Cordova Research Institute, LLC Miami Florida 33155 —
Clinical Trials of Florida, LLC Miami Florida 33186 —
The Clinical Research Institute LLC Miami Gardens Florida 33169 —
Pembroke Clinical Trials Pembroke Pines Florida 33028 —
Luminous Clinical Research LLC - South Florida Urgent Care - Infectious Diseases Pembroke Pines Florida 33029-2818 —
Palm Beach Research Center West Palm Beach Florida 33409 —
Florida Pulmonary Research Institute, LLC Winter Park Florida 32789 —
Excel Clinical Research - Internal Medicine Las Vegas Nevada 89109 —
Temple University Health System - Temple Lung Center Philadelphia Pennsylvania 19140-5103 —
Zenos Clinical Research Dallas Texas 75230 —
Epic Clinical Research Lewisville Texas 75057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05162365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2023 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05162365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →